Impax Asset Management Group
BSX icon

Impax Asset Management Group’s Boston Scientific BSX Stock Holding History

Impax Asset Management Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.5M Sell
1,159,186
-200,386
-15% -$10.9M 0.32% 68
2026
Q1 		$85.3M Sell
1,359,572
-364,355
-21% -$29.1M 0.59% 47
2025
Q4 		$164M Sell
1,723,927
-3,453
-0.2% -$339K 1.03% 32
2025
Q3 		$169M Buy
1,727,380
+277,644
+19% +$28.8M 0.98% 34
2025
Q2 		$154M Sell
1,449,736
-15,034
-1% -$1.52M 0.89% 40
2025
Q1 		$146M Sell
1,464,770
-3,040,709
-67% -$306M 0.88% 40
2024
Q4 		$401M Sell
4,505,479
-964,695
-18% -$84.9M 1.82% 13
2024
Q3 		$457M Buy
5,470,174
+815,403
+18% +$64.3M 1.8% 12
2024
Q2 		$358M Buy
4,654,771
+189,705
+4% +$13.9M 1.46% 16
2024
Q1 		$305M Buy
4,465,066
+123,021
+3% +$7.91M 1.17% 27
2023
Q4 		$250M Buy
4,342,045
+80,071
+2% +$4.27M 1.01% 32
2023
Q3 		$225M Sell
4,261,974
-1,774,667
-29% -$93.1M 1% 31
2023
Q2 		$326M Sell
6,036,641
-941,770
-13% -$49.2M 1.31% 22
2023
Q1 		$348M Sell
6,978,411
-45,023
-0.6% -$2.12M 1.46% 16
2022
Q4 		$324M Buy
7,023,434
+402,301
+6% +$17.4M 1.45% 17
2022
Q3 		$256M Buy
6,621,133
+2,132,468
+48% +$85.5M 1.32% 20
2022
Q2 		$167M Buy
+4,488,665
New +$183M 0.82% 47

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Impax Asset Management Group's BSX Position: Q2 2026 in Review

Impax Asset Management Group reduced its Boston Scientific (BSX) stake by 15% in Q2 2026, selling an estimated $10.9M and leaving 1,159,186 shares worth $49.5M. The position accounts for 0.32% of the portfolio, ranked #68.

Impax Asset Management Group first reported a position in BSX in Q2 2022 and has held it in 17 quarters since. The position peaked at $457M in Q3 2024. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Impax Asset Management Group held 1,159,186 shares of Boston Scientific worth $49.5M as of Q2 2026.
  • Impax Asset Management Group sold 200,386 Boston Scientific shares in Q2 2026, an estimated $10.9M.
  • Boston Scientific made up 0.32% of Impax Asset Management Group's portfolio in Q2 2026, its #68 holding.
  • Impax Asset Management Group first reported a position in Boston Scientific in Q2 2022 and has held it in 17 quarters since.
  • Impax Asset Management Group's Boston Scientific position peaked at $457M in Q3 2024.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.